Dr. Amol Adkonkar is a Senior Lecturer in the Healthcare Management area at Goa Institute of Management, with a Ph.D. and MBA in Pharmaceutical Management from NIPER S.A.S. Nagar. His expertise spans pharmaceutical supply chain management, strategy, market access, business development, competitive intelligence, and healthcare operations. His research focuses on SCM practices, SCM agility, competitive advantage, organizational performance, pharmaceutical supply-chain performance, and healthcare/pharmaceutical operations. His doctoral work studied supply chain management practices and performance of Indian pharmaceutical firms using primary data from 227 pharmaceutical-industry respondents and tools such as SPSS, Neural Networks, and SmartPLS. He currently teaches Operations Management, Operations Research, Supply Chain Management, KYHP, Strategic Pharmaceutical Management, and Business Development, while developing applied healthcare and pharmaceutical-sector learning material.

Publications:

Journals

• Adkonkar, A., Sharma, A., & Arora, P. (2025). Is There a Difference in Supply Chain Management Practices, Competitive Advantage, Organizational Performance, and Supply Chain Agility Between Listed and Unlisted Pharmaceutical Companies? BIMTECH Business Perspectives, 6(1), 45–65. The study used responses from 192 senior supply-chain professionals and compared listed and unlisted pharmaceutical firms on SCMP, competitive advantage, organizational performance, and SCM agility.
• Adkonkar, A., Sharma, A., & Arora, P. (2024). Validation of Instrument Measuring the Impact of SCM Practices and SCM Agility on Competitive Advantage and Organization Performance in Indian Pharmaceutical Firms. Paradigm, 28(1), 65–83. The paper developed and validated a questionnaire using 227 responses from listed and unlisted pharmaceutical companies, analysed using IBM SPSS 26 and SmartPLS 4.
• Dangi, R. R., Adkonkar, A., Arora, P., & Sharma, A. (2023). Impact of Information, Technology Infrastructure, Inventory Management and Demand on the Overall Performance of the Pharmaceutical Supply Chain. Paradigm, 27(2), 211–228. The study found that information, technology infrastructure, inventory management, and demand positively influence pharmaceutical supply-chain performance.
• Angrish, A. K., Batra, R., Bansal, S. K., & Adkonkar, A. (2023). Renewable Natural Capital and Energy for Sustainable Development in India: A Study of Pharmaceutical Industry in India. The Management Accountant Journal, 58(10), 30–37.
  
   

Book Chapters

• Adkonkar, A., Angrish, A. K., & Bansal, S. (2023). Goods and Services Tax (GST) Evasion: An Analysis of Mechanisms adopted by Tax Evaders. In Contemporary Issues and Emerging Dimensions in Finance, Accounting, Economics, Banking and Management, pp. 177–183, Rubicons Publications.
• Adkonkar, A., Angrish, A. K., & Bansal, S. (2023). Counter Measures adopted in Taxation System to Prevent and Combat GST Evasion in India: An Analysis. In Contemporary Issues and Emerging Dimensions in Finance, Accounting, Economics, Banking and Management, pp. 15–21, Rubicons Publications.
• Angrish, A. K., Adkonkar, A., Sharma, A., & Bansal, S. (2022). Strategic Advantage in Pharmaceutical Sector through Innovations: An Analysis of Top Pharmaceutical Companies in India. In Emerging Trends in Management, Social Science & Information Technology, pp. 89–106, Rubicons Publications.
• Angrish, A. K., Bansal, S., Adkonkar, A., & Vishal. (2022). A Paradigm Shift in Pharmaceutical Marketing. In Paradigm Shifts in Marketing and Finance, Bharti Publications.